Management of bullous pemphigoid: The European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

C. Feliciani, P. Joly, M. F. Jonkman, G. Zambruno, D. Zillikens, D. Ioannides, C. Kowalewski, H. Jedlickova, S. Kárpáti, B. Marinovic, D. Mimouni, S. Uzun, S. Yayli, M. Hertl, L. Borradori

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients, bullae may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. Our consensus for the treatment of bullous pemphigoid has been developed under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations.

Original languageEnglish
Pages (from-to)867-877
Number of pages11
JournalBritish Journal of Dermatology
Volume172
Issue number4
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Venereology
Bullous Pemphigoid
Dermatology
Blister
Prurigo
Nervous System Diseases
Skin Diseases
Mucous Membrane
Quality of Life
Guidelines
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Dermatology
  • Medicine(all)

Cite this

Management of bullous pemphigoid : The European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. / Feliciani, C.; Joly, P.; Jonkman, M. F.; Zambruno, G.; Zillikens, D.; Ioannides, D.; Kowalewski, C.; Jedlickova, H.; Kárpáti, S.; Marinovic, B.; Mimouni, D.; Uzun, S.; Yayli, S.; Hertl, M.; Borradori, L.

In: British Journal of Dermatology, Vol. 172, No. 4, 01.04.2015, p. 867-877.

Research output: Contribution to journalArticle

Feliciani, C, Joly, P, Jonkman, MF, Zambruno, G, Zillikens, D, Ioannides, D, Kowalewski, C, Jedlickova, H, Kárpáti, S, Marinovic, B, Mimouni, D, Uzun, S, Yayli, S, Hertl, M & Borradori, L 2015, 'Management of bullous pemphigoid: The European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology', British Journal of Dermatology, vol. 172, no. 4, pp. 867-877. https://doi.org/10.1111/bjd.13717
Feliciani, C. ; Joly, P. ; Jonkman, M. F. ; Zambruno, G. ; Zillikens, D. ; Ioannides, D. ; Kowalewski, C. ; Jedlickova, H. ; Kárpáti, S. ; Marinovic, B. ; Mimouni, D. ; Uzun, S. ; Yayli, S. ; Hertl, M. ; Borradori, L. / Management of bullous pemphigoid : The European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. In: British Journal of Dermatology. 2015 ; Vol. 172, No. 4. pp. 867-877.
@article{0ad81ed3bfd640b89d0dfddbbd06233a,
title = "Management of bullous pemphigoid: The European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology",
abstract = "Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20{\%} of affected patients, bullae may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. Our consensus for the treatment of bullous pemphigoid has been developed under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations.",
author = "C. Feliciani and P. Joly and Jonkman, {M. F.} and G. Zambruno and D. Zillikens and D. Ioannides and C. Kowalewski and H. Jedlickova and S. K{\'a}rp{\'a}ti and B. Marinovic and D. Mimouni and S. Uzun and S. Yayli and M. Hertl and L. Borradori",
year = "2015",
month = "4",
day = "1",
doi = "10.1111/bjd.13717",
language = "English",
volume = "172",
pages = "867--877",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - Management of bullous pemphigoid

T2 - The European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

AU - Feliciani, C.

AU - Joly, P.

AU - Jonkman, M. F.

AU - Zambruno, G.

AU - Zillikens, D.

AU - Ioannides, D.

AU - Kowalewski, C.

AU - Jedlickova, H.

AU - Kárpáti, S.

AU - Marinovic, B.

AU - Mimouni, D.

AU - Uzun, S.

AU - Yayli, S.

AU - Hertl, M.

AU - Borradori, L.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients, bullae may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. Our consensus for the treatment of bullous pemphigoid has been developed under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations.

AB - Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients, bullae may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. Our consensus for the treatment of bullous pemphigoid has been developed under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations.

UR - http://www.scopus.com/inward/record.url?scp=84943590639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943590639&partnerID=8YFLogxK

U2 - 10.1111/bjd.13717

DO - 10.1111/bjd.13717

M3 - Article

C2 - 25827742

AN - SCOPUS:84943590639

VL - 172

SP - 867

EP - 877

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 4

ER -